Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - PROGENICS PHARMACEUTICALS INC | Financial_Report.xls |
| EX-32 - PROGENICS EXHIBIT 32 09/30/2011 - PROGENICS PHARMACEUTICALS INC | ex3209302011.htm |
| EX-31.1 - PROGENICS EXHIBIT 31.1 09/30/2011 - PROGENICS PHARMACEUTICALS INC | ex31_109302011.htm |
| EX-31.2 - PROGENICS EXHIBIT 31.2 09/30/2011 - PROGENICS PHARMACEUTICALS INC | ex31_209302011.htm |
| 10-Q - PROGENICS FORM 10-Q 09/30/2011 - PROGENICS PHARMACEUTICALS INC | form10_q09302011.htm |
Exhibit 12.1
Progenics Pharmaceuticals, Inc.
Ratio of Earnings (Loss) to Combined Fixed Charges and Preferred Stock Dividends
(in thousands)
|
Nine Months
Ended
September 30,
|
Years Ended December 31,
|
||||||||||||||||||
|
2011
|
2010
|
2009
|
2008
|
2007
|
2006
|
||||||||||||||
|
Determination of earnings (loss):
|
|||||||||||||||||||
|
Income (loss) from operations(1)
|
$
|
21,127
|
$
|
(69,820
|
)
|
$
|
(30,612
|
)
|
$
|
(44,672
|
)
|
$
|
(43,688
|
)
|
$
|
(21,497
|
)
|
||
|
Add:
|
|||||||||||||||||||
|
Fixed charges
|
492
|
709
|
555
|
594
|
483
|
339
|
|||||||||||||
|
Earnings (loss), as adjusted
|
$
|
21,619
|
$
|
(69,111
|
)
|
$
|
(30,057
|
)
|
$
|
(44,078
|
)
|
$
|
(43,205
|
)
|
$
|
(21,158
|
)
|
||
|
Fixed charges:
|
|||||||||||||||||||
|
Estimate of interest within rental expense
|
492
|
709
|
555
|
594
|
483
|
339
|
|||||||||||||
|
Fixed charges
|
$
|
492
|
$
|
709
|
$
|
555
|
$
|
594
|
$
|
483
|
$
|
339
|
|||||||
|
Preferred stock dividends
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
|||||||
|
Ratio of earnings (loss) to fixed charges and preferred stock dividends
|
44
|
*
|
*
|
*
|
*
|
*
|
|||||||||||||
|
Coverage deficiency amount for total fixed charges and preferred stock dividends (2)
|
-
|
$
|
69,820
|
$
|
30,612
|
$
|
44,672
|
$
|
43,688
|
$
|
21,497
|
||||||||
_____________________
(1) Excludes loss in joint venture of $121 in 2006.
|
(2)
|
For the full years presented, the Company’s coverage ratio is less than one-to-one and it must generate additional earnings of these specified amounts to achieve a coverage ratio of 1:1.
|